Advertisement

Taurine 11 pp 977-985 | Cite as

Taurine Regulation of Neuroendocrine Function

  • Abdeslem El IdrissiEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1155)

Abstract

Taurine (2-aminoethanesulfonic acid) is a sulfur-containing amino acid. It is one of the most abundant free amino acids in many excitable tissues, including the brain, skeletal and cardiac muscles. Physiological actions of taurine are widespread and include regulation of plasma glucose levels, bile acid conjugation, detoxification, membrane stabilization, blood pressure regulation, osmoregulation, neurotransmission, and modulation of mitochondria function and cellular calcium levels. Taurine plays an important role in modulating glutamate and GABA neurotransmission and prevents excitotoxicity in vitro primarily through modulation of intracellular calcium homeostasis. Taurine supplementation prevents age-dependent decline of cognitive functions. Because of the wide spread actions of taurine, its levels are highly regulated through enzymatic biosynthesis or dietary intake. Furthermore, depletion of endogenous or dietary supplementation of exogenous taurine have been shown to induce wide spread actions on multiple organs. Cysteine sulfonic acid decarboxylase (CSAD) was first identified in the liver and is thought to be the rate-limiting enzyme in taurine biosynthesis. CSAD mRNA is expressed in the brain in astrocytes. Homozygous knockout mice lacking CSAD (CSAD-KO) have very reduced taurine content and show severe functional histopathology in the visual system, skeletal system, heart, pancreas and brain. Conversely, dietary supplementation of taurine results in significant health benefits acting through the same organ systems. Fluctuation of taurine bioavailability lead to changes in the expression levels of taurine transporters in neuronal plasma membranes, endothelial cells forming the blood-brain barrier and proximal cells of the kidneys. Suggesting a highly regulated mechanism for maintaining taurine homeostasis and organ systems function. Here we show how alterations in taurine levels directly affect the function of one organ system and through functional interaction and compensatory adaptation; these effects extend to another organ systems with focus on the nervous system.

Keywords

CSAD KO Taurine supplementation Neuroendocrine alteration Glut4 Insulin receptor calbindin Na-K-ATPase 

Abbreviations

CSAD KO

cysteine sulfinic acid decarboxylase knock-out mice

CSAD

cysteine sulfinic acid decarboxylase

Glut4

glucose transporter 4

IR

insulin receptor

TAU

taurine

TauT

taurine transporter

VSCC

voltage sensitive calcium channels

Notes

Acknowledgement

This work was supported by CDN, PSC-CUNY and CSI. The author declares that he has no conflict of interest. This chapter was modified from the paper published by our group in Advances in Experimental Biology and Medicine. The related contents are re-used with the permission.

References

  1. Arany E, Strutt B, Romanus P, Remacle C, Reusens B, Hill DJ (2004) Taurine supplement in early life altered islet morphology, decreased insulitis and de-layed the onset of diabetes in non-obese diabetic mice. Diabetologia 47:1831–1837CrossRefGoogle Scholar
  2. El Idrissi A, Trenkner E (2003) Taurine regulates Mitochondrial calcium homeostasis. Adv Exp Med Biol 526:527–536Google Scholar
  3. El Idrissi A, Yan X, Sidime F, L’Amoreaux W (2010, Aug 24) Neuro-endocrine basis for altered plasma glucose homeostasis in the fragile X mouse. J Biomed Sci 17(Suppl 1):S8CrossRefGoogle Scholar
  4. El Idrissi A, Okeke E, Yan X, Sidime F, Neuwirth LS (2013) Taurine regulation of blood pressure and vasoactivity. Adv Exp Med Biol 775:407–425Google Scholar
  5. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163CrossRefGoogle Scholar
  6. Levinskaya N, Trenkner E, El Idrissi A (2006) Increased GAD-positive neurons in the cortex of taurine-fed mice. Adv Exp Med Biol 583:411–417CrossRefGoogle Scholar
  7. Liu Y, Tonna-DeMasi M, Park E, Schuller-Levis G, Quinn MR (1998) Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in acti-vated C6 glioma cells by suppressing inducible nitric oxide synthase and cy-clooxygenase-2 expression. Brain Res Mol Brain Res 59:189–195CrossRefGoogle Scholar
  8. Marks DR, Tucker K, Cavallin MA, Mast TG, Fadool DA (2009) Awake intrana-sal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci 29:6734–6751CrossRefGoogle Scholar
  9. Mielke JG, Taghibiglou C, Wang YT (2006) Endogenous insulin signaling protects cultured neurons from oxygen–glucose deprivation-induced cell death. Neuroscience 143:165–173CrossRefGoogle Scholar
  10. Petrik J, Arany E, McDonald TJ, Hill DJ (1998) Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 139:2994–3004CrossRefGoogle Scholar
  11. Plum L, Schubert M, Brüning JC (2005) The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16:59–65CrossRefGoogle Scholar
  12. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736–1741CrossRefGoogle Scholar
  13. Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:95–202CrossRefGoogle Scholar
  14. Schuller-Levis GB, Park E (2006) Is Taurine a biomarker? Adv Clin Chem 41:1–21Google Scholar
  15. Schuller-Levis G, Gordon RE, Yong CWS, Park E (2009) Protection of bleomycin-induced fibrosis and inflammation by taurine. Int Immunopharmacol 9(7–8):971–977CrossRefGoogle Scholar
  16. Schaffer SW, Ju Jong C, KC R, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17(Suppl 1):S2CrossRefGoogle Scholar
  17. Sturman JA (1993) Taurine in development. Physiol Rev 73(1):119–147CrossRefGoogle Scholar
  18. Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36:343–362CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Biology, Center for Developmental NeuroscienceCollege of Staten IslandStaten IslandUSA

Personalised recommendations